On February 8, the refinancing of three main board listed companies, Yueyang Lin Paper, Will Pharmaceutical and Aonong Biotechnology, was announced to be terminated, and the direct reason was that the company and the sponsor applied to withdraw the application for sponsorship. Recently, there have been many voices of tightening the refinancing of listed companies, and the termination of refinancing in three cases a day may be one of the impacts.
In addition, according to the statistics of financial magazines, in the past ten years, the total scale of IPOs has been 2,951.3 billion yuan, and the total scale of SPOs (refinancing, including additional issuance and allotment) has reached 9,678 billion yuan, which is 32 times.
Refinancing
Deep motherboard
Deadline: February 18, 2024.
GEM
Deadline: February 18, 2024.
Shanghai Main Board
Deadline: February 18, 2024.
Science and Technology Innovation Board
Deadline: February 18, 2024.
M&A and restructuring
Deep motherboard
Deadline: February 18, 2024.
GEM
Deadline: February 18, 2024.
Shanghai Main Board
Deadline: February 18, 2024.
Science and Technology Innovation Board
Deadline: February 18, 2024.
At the end of the full text, if you like it, please light up "Watching" and put it in the circleStatement: This *** is committed to good article push, and the copyright belongs to the original author! The article is for reference only, please do not follow the information in this subscription account to invest on your own, if the improper use of relevant information causes any direct or indirect losses, you need to bear full responsibility. If copyright issues are involved, please contact us.